JPRN-UMIN000007771
Recruiting
Phase 2
Clinical study to evaluate the efficacy and safety of LH-RH agonist alternative therapy on prostate cancer patients who relapsed after combined androgen blockade. - Clinical study to evaluate the efficacy and safety of LH-RH agonist alternative therapy on prostate cancer patients who relapsed after combined androgen blockade.
Department of Urology, Ibaraki Prefecture Central Hospital0 sites60 target enrollmentOctober 1, 2012
ConditionsProstate cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Department of Urology, Ibaraki Prefecture Central Hospital
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who have not observed anti\-androgen withdrawal syndrome(AWS) 2\)Treated with steroid drug 3\)Undergone bilateral orchidectomy 4\)Treated with chemotherapy 5\)Treated with anti\-androgen for benign prostate hyperplasia(BPH) 6\)Considered inappropriate for this study by physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
Clinical study to evaluate the efficacy and safety of TA-650 in patients with psoriasisPsoriasisJPRN-jRCT2080220313Mitsubishi Tanabe Pharma Corporation
Completed
Phase 3
result of vitimelin tablet and vitimelin oil in vitiligoHealth Condition 1: L80- VitiligoCTRI/2021/04/033014DrVasishths Ayuremedies30
Completed
Phase 2
A study for Under eye dark circlesCTRI/2022/09/045732Transformative Learning Solutions Pvt Ltd32
Active, Not Recruiting
N/A
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/AEUCTR2005-003552-35-DEOctapharma AG116
Completed
Phase 2
Clinical study on Dabur gel in reduction of oral malodor.Health Condition 1: R196- HalitosisCTRI/2021/07/034750Dabur India limited161